Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Zhengyan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4906-4481; OpenAlex author ID A5027367137, A5120218364. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2023: 1 paper · 2024: 3 papers

Papers 4

  1. SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer. Co-author DOI 10.1002/advs.202402244↗
  2. Deciphering the pancreatic cancer microbiome in Mainland China: Impact of Exiguobacterium/Bacillus ratio on tumor progression and prognostic significance. Co-author DOI 10.1016/j.phrs.2024.107197↗
  3. MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2024-332350↗
  4. Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s13402-023-00831-8↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Xue · 4 shared papers, 2023–2024 · strength 0.82
  2. Junyi Xu · 3 shared papers, 2023–2024 · strength 0.58
  3. Massimiliano Mazzone · 2 shared papers, 2024 · strength 0.38
  4. Yingying Tang · 2 shared papers, 2024 · strength 0.38
  5. Yongwei Sun · 2 shared papers, 2024 · strength 0.38
  6. Wei Wang · 1 shared paper, 2024 · strength 0.24
  7. Huaizhi Wang · 1 shared paper, 2024 · strength 0.24
  8. Xuqing Shen · 1 shared paper, 2023 · strength 0.20
  9. Xiaotong Yang · 1 shared paper, 2023 · strength 0.20
  10. Wei Wang · 1 shared paper, 2023 · strength 0.20
  11. Ningning Niu · 1 shared paper, 2024 · strength 0.20
  12. Christian P. Pilarsky · 1 shared paper, 2024 · strength 0.18
  13. Ruijun Tian · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.